Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant middle-of-the-night pharmacodynamic crossover study in healthy adults and elderly subjects
NL-OMON51304Completed
- Sponsor
- Idorsia
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of daridorexant, sponsored by Idorsia. Started Jan 2023; status: completed.
02
Drugs
daridorexant
Beyond the preview
Go deeper on NL-OMON51304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51304.